Du Lihuan, M.D., Ph.D.

Department:Urology

Medical School:Shanghai Medical College of Fudan University, China 

Academic Rank:Associate Chief Physician

Appointment

Clinical / Research Interests

Laparoscopic and robotic-assisted urological surgery

Minimally invasive treatment of urological cancer, urinary calculi and prostate disease

Photodynamic therapy for urological cancer 

Diagnostic and prognostic markers for urological cancer 

Professional Highlights

Professional Appointments

Professional Member, American Urological Association (AUA)

Professional Member, European Association of Urology (EAU)

Professional Member, Chinese Urological Association (CUA)

Professional Member, Endourological Society

Professional Member, Society of Urologic Oncology

Editorial Board Member, Technology in Cancer Research & Treatment

Peer reviewer, Autophagy, Translation oncology, Cancer medicine, Heliyon, Medical Science Monitor, Gene, Chemosphere, Journal of affective disorders, Molecular Biotechnology, Urologic oncology and BBA - Molecular Basis of Disease

Education Experience

2011.09-2014.06: Doctor in Medcine, Clinical Urology, Shanghai Medical college of Fudan University, Shanghai, China

2013.06-2013.09: Visiting Scholar at the Urological Laboratory and Division of Experimental Urology, Innsbruck Medical University, Innsbruck, Austria

2008.09-2011.06: Master in Medicine, Clinical Urology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China

2003.09-2008.06: Bachelor in Medicine, Tongji Medical college of Huazhong University of Science and Technology, Wuhan, China

Research Summary

Dr. Du's research interest is photodynamic therapy for urological cancer, diagnostic and prognostic markers for urological cancer. He specializes in the diagnosis and treatment of urological diseases, including benign prostatic hyperplasia, urinary stones and urological tumors,et.al.

Publications

Xianguo Chen, Fei Liu, Xingfu Song, Zhihua Wang, Ziqiang Dong, Zhiquan Hu, Ruzhu Lan,Wei Guan, Tiangui Zhou, Xiaoming Xu, Hong Lei, Zhangqun Ye, Ejun Peng, Lihuan Du. Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways. Mol Carcinog. 2010;49(6):603-610.

Wang Zhihua, Du Lihuan, Hu Zhiquan, Chen Xianguo, Zhao Xia, Wang Shaogang, Zhuang Qianyuan, Ye Zhangqun. Clinical features on chromophobe renal cell carcinoma. Zhonghua Wai Ke Za Zhi. 2011;49(4): 320-323.

Zhihua Wang,Tong Lu, Lihuan Du, Zhiquan Hu, Qianyuan Zhuang, Youyuan Li, Congyi Wang, Hui Zhu, Zhangqun Ye. Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review. Int J Clin Exp Pathol. 2012;5(6):601-608.

Du Lihuan, Jiang Ning, Wang Guozeng, Chu Yiwei, Lin Wei, Qian Jing, Zhang Yuanfang, Zheng Jingcun, Chen Gang. Autophagy inhibition sensitizes bladder cancer cells to the photodynamic effects of the novel photosensitizer chlorophyllin e4. J Photochem Photobiol B. 2014;133:1-10.

Lihuan Du, Jingcun Zheng, Ning Jiang, Guozeng Wang, Yiwei Chu, Wei Lin, Jing Qian, Yuanfang Zhang, Gang Chen. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells. Lasers Surg Med. 2014;46(4): 319-334.

Du Lihuan, Zhang Yong, Zhang Nan, Zheng Yichun,Chen Jimin.Case report of inguinal metastasis of epididymal malignant mesothelioma. Int Urol Nephrol. 2019;51(2):263-264.

Du Lihuan, Zhang Zhewei. Delayed right external iliac artery disruption after radical cystectomy: A case report and literature review. Mol Clin Oncol. 2023;19(3):74. 

Du Lihuan, Wang Bohan, Wen Jiaming, Zhang Nan. Examining the causal association between psoriasis and bladder cancer: A two-sample Mendelian randomization analysis. Skin Res Technol. 2024;30(4):e13663.

Du Lihuan, Wang Bohan, Wen Jiaming, Zhang Nan. No causal association between insomnia and bladder cancer: a bidirectional two-sample Mendelian randomization study. Eur J Med Res. 2024;29(1):316.

Du Lihuan, Zhang Nan, Wang Bohan, Cheng Wei, Wen Jiaming. Establishment and validation of a novel disulfidptosis-related immune checkpoint gene signature in clear cell renal cell carcinoma. Discov Oncol. 2024;15(1):236.  


Current Program

National Natural Science Foundation of China, No. 82374080

The role of TRIM70 in photodynamic therapy with chlorophyllin e4 for bladder cancer and its mechanisms. 

Find People

Search by Family Name

Find A Department

Search by Departments